BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18980829)

  • 1. [Thyrotropin-secreting pituitary adenomas].
    Caron P
    Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G; Podgórski JK; Warczyńska A; Koziarski A; Zgliczyński W
    Przegl Lek; 2002; 59(12):1018-23. PubMed ID: 12731380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M; Fortunato M; Molteni L; Peretti E; Mortini P
    Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM; Arlot S; Lefebvre H; Caron P; Cortet-Rudelli C; Archambaud F; Chanson P; Tabarin A; Goth MI; Blumberg J; Catus F; Ispas S; Beck-Peccoz P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
    Macchia E; Gasperi M; Lombardi M; Morselli L; Pinchera A; Acerbi G; Rossi G; Martino E
    J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
    Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P; Díez JJ
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
    Gannage MH; Maacaron C; Okais N; Halaby G
    J Med Liban; 1997; 45(2):97-101. PubMed ID: 9289506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New elements in the diagnosis and treatment of thyrotropic pituitary adenomas with hyperthyroidism].
    Linquette M; Cappoen JP; Mazzuca M
    Bull Acad Natl Med; 1989 Feb; 173(2):217-20; discussion 221-2. PubMed ID: 2765997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
    Nazato DM; Abucham J
    J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ; Erickson D; Castro MR; Atkinson JL
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH-secreting pituitary adenomas: follow-up of 11 cases and review of the literature.
    Ness-Abramof R; Ishay A; Harel G; Sylvetzky N; Baron E; Greenman Y; Shimon I
    Pituitary; 2007; 10(3):307-10. PubMed ID: 17347873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of thyrotropin-secreting pituitary adenomas.
    Beck-Peccoz P; Persani L
    Pituitary; 2002; 5(2):83-8. PubMed ID: 12675505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyrotropin-producing hypophyseal adenomas].
    Calvo Romero JM; Morales Pérez F; Alvarez Barreiro JA; Díaz Pérez de Madrid J
    Rev Clin Esp; 1999 May; 199(5):285-7. PubMed ID: 10396149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Manifestations and prognosis of thyrotropin-secreting pituitary adenomas: a case series of three patients].
    Latrech H; Rousseau A; Le Marois E; Billaud L; Bertagna X; Azzoug S; Raffin-Sanson ML
    Rev Med Interne; 2010 Dec; 31(12):858-62. PubMed ID: 21074296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
    J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.